David Saperstein

4.3k total citations
60 papers, 2.2k citations indexed

About

David Saperstein is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, David Saperstein has authored 60 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Neurology, 19 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in David Saperstein's work include Peripheral Neuropathies and Disorders (20 papers), Hereditary Neurological Disorders (14 papers) and Amyotrophic Lateral Sclerosis Research (11 papers). David Saperstein is often cited by papers focused on Peripheral Neuropathies and Disorders (20 papers), Hereditary Neurological Disorders (14 papers) and Amyotrophic Lateral Sclerosis Research (11 papers). David Saperstein collaborates with scholars based in United States, Canada and Italy. David Saperstein's co-authors include Richard J. Barohn, Jonathan Katz, Anthony A. Amato, Richard J. Barohn, Sharon Nations, Gil I. Wolfe, Gary Gronseth, Todd Levine, J.S. Katz and Wilson W. Bryan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Annals of Neurology.

In The Last Decade

David Saperstein

54 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Saperstein United States 21 1.4k 824 463 360 344 60 2.2k
Tatsuo Kohriyama Japan 27 988 0.7× 543 0.7× 332 0.7× 146 0.4× 344 1.0× 104 2.2k
J. T. Kissel United States 28 1.0k 0.8× 817 1.0× 429 0.9× 246 0.7× 251 0.7× 50 2.8k
Ricard Rojas‐García Spain 29 2.1k 1.6× 802 1.0× 182 0.4× 162 0.5× 269 0.8× 67 3.1k
Julia Wanschitz Austria 26 715 0.5× 594 0.7× 287 0.6× 182 0.5× 100 0.3× 78 1.9k
Nicolette C. Notermans Netherlands 30 1.8k 1.3× 1.4k 1.7× 115 0.2× 232 0.6× 515 1.5× 114 2.9k
Leslie Bridges United Kingdom 27 834 0.6× 222 0.3× 492 1.1× 199 0.6× 123 0.4× 78 2.4k
A Lagueny France 25 1.3k 0.9× 776 0.9× 132 0.3× 264 0.7× 164 0.5× 106 2.1k
Minoru Shigemori Japan 26 1.3k 1.0× 367 0.4× 515 1.1× 178 0.5× 128 0.4× 232 2.8k
Oren Tomkins‐Netzer United Kingdom 29 369 0.3× 560 0.7× 220 0.5× 256 0.7× 482 1.4× 94 3.2k
Peter Van den Bergh Belgium 31 2.6k 1.9× 2.0k 2.5× 123 0.3× 265 0.7× 788 2.3× 80 4.0k

Countries citing papers authored by David Saperstein

Since Specialization
Citations

This map shows the geographic impact of David Saperstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Saperstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Saperstein more than expected).

Fields of papers citing papers by David Saperstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Saperstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Saperstein. The network helps show where David Saperstein may publish in the future.

Co-authorship network of co-authors of David Saperstein

This figure shows the co-authorship network connecting the top 25 collaborators of David Saperstein. A scholar is included among the top collaborators of David Saperstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Saperstein. David Saperstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blitshteyn, Svetlana, et al.. (2024). Internal Tremor in Long COVID May Be a Symptom of Dysautonomia and Small Fiber Neuropathy. Neurology International. 17(1). 2–2. 1 indexed citations
2.
Blitshteyn, Svetlana, Glenn J. Treisman, David Saperstein, et al.. (2024). Postural orthostatic tachycardia syndrome and other common autonomic disorders are not functional neurologic disorders. Frontiers in Neurology. 15. 1490744–1490744. 2 indexed citations
3.
Barohn, Richard J., Mazen M. Dimachkie, Todd Levine, David Saperstein, & Jonathan Katz. (2024). Pattern Recognition of Neuropathy and Neuronopathy. Macedonian Journal of Medical Sciences (University of Skopje). 5(1).
4.
Bhai, Salman, Gil I. Wolfe, Laura Herbelin, et al.. (2023). Quantitative sensory testing in a large cohort of neuropathy patients. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 4(2). 29–33.
5.
Pasnoor, Mamatha, Vera Bril, Todd Levine, et al.. (2023). Phase 2 trial in acetylcholine receptor antibody‐positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg study. European Journal of Neurology. 30(5). 1417–1424. 2 indexed citations
6.
Saperstein, David. (2020). Small Fiber Neuropathy. Neurologic Clinics. 38(3). 607–618. 9 indexed citations
7.
Dimachkie, Mazen M., Vera Bril, Todd Levine, et al.. (2019). Subcutaneous Immunoglobulin in Myasthenia Gravis: Results of a North American Open Label Study (N4.002). Neurology. 92(15_supplement). 5 indexed citations
8.
Levine, Todd, David Saperstein, Alan Pestronk, & Jack W. Kent. (2017). Identification of a Novel Immune Mediated Cause for Small Fiber Neuropathy (P4.137). Neurology. 88(16_supplement). 4 indexed citations
9.
Saperstein, David & Todd Levine. (2016). Interim Analysis of a Pilot Trial of Natalizumab in Inclusion Body Myositis (P3.161). Neurology. 86(16_supplement). 7 indexed citations
10.
Levine, Todd, David Saperstein, Nicole Hank, et al.. (2013). ADAPT: Acthar in Dermatomyositis and Polymyositis Treatment Registry (P07.041). Neurology. 80(7_supplement). 1 indexed citations
11.
Levine, Todd & David Saperstein. (2013). Laboratory Evaluation of Peripheral Neuropathy. Neurologic Clinics. 31(2). 363–376. 8 indexed citations
12.
Mittal, Manoj, Mamatha Pasnoor, April McVey, et al.. (2011). Retrospective Chart Review of Duloxetine and Pregabalin in the Treatment of Painful Neuropathy. International Journal of Neuroscience. 121(9). 521–527. 14 indexed citations
13.
Saperstein, David. (2008). Muscle Channelopathies. Seminars in Neurology. 28(2). 260–269. 6 indexed citations
14.
Saperstein, David. (2007). Muscle Histochemistry: Routine Techniques and Their Clinical Use. Journal of Histotechnology. 30(4). 249–256. 1 indexed citations
15.
Saperstein, David. (2006). MUSCLE CHANNELOPATHIES. CONTINUUM Lifelong Learning in Neurology. 12(3). 121–139.
16.
Grogan, Pauline, Scott Tanner, K.H. Örstavik, et al.. (2005). Myopathy with skeletal asymmetry and hemidiaphragm elevation is caused by myotubularin mutations. Neurology. 64(9). 1638–1640. 21 indexed citations
17.
Saperstein, David & Richard J. Barohn. (2004). Management of Myasthenia Gravis. Seminars in Neurology. 24(1). 41–48. 36 indexed citations
18.
Katz, Jonathan & David Saperstein. (2003). Chronic inflammatory demyelinating polyneuropathy. Current Treatment Options in Neurology. 5(5). 357–364. 9 indexed citations
19.
Katz, Jonathan & David Saperstein. (2001). Asymmetric acquired demyelinating polyneuropathies: MMN and MADSAM. Current Treatment Options in Neurology. 3(2). 119–125. 15 indexed citations
20.
Saperstein, David, Anthony A. Amato, Gil I. Wolfe, et al.. (1999). Multifocal acquired demyelinating sensory and motor neuropathy: The Lewis-Sumner syndrome. Muscle & Nerve. 22(5). 560–566. 190 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsuo Kohriyama Breakdown of academic impact, for papers by J. T. Kissel Breakdown of academic impact, for papers by Ricard Rojas‐García Breakdown of academic impact, for papers by Julia Wanschitz Breakdown of academic impact, for papers by Nicolette C. Notermans Breakdown of academic impact, for papers by Leslie Bridges Breakdown of academic impact, for papers by A Lagueny Breakdown of academic impact, for papers by Minoru Shigemori Breakdown of academic impact, for papers by Oren Tomkins‐Netzer Breakdown of academic impact, for papers by Peter Van den Bergh
Rankless by CCL
2026